Eiger BioPharmaceuticals
(NASDAQ:EIGR)
6.46
0.22[3.53%]
Last update: 2:54PM
15 minutes delayed
Day High/Low6.09 - 6.55
52 Week High/Low3.53 - 10.02
Open / Close6.3 / -
Float / Outstanding35.7M / 43.2M
Vol / Avg.194.9K / 577.9K
Mkt Cap279.2M
P/E-
50d Avg. Price6.47
Div / Yield-
Payout Ratio-
EPS-0.64
Total Float35.7M

Eiger BioPharmaceuticals (NASDAQ:EIGR), Quotes and News Summary

Eiger BioPharmaceuticals (NASDAQ: EIGR)

Day High/Low6.09 - 6.55
52 Week High/Low3.53 - 10.02
Open / Close6.3 / -
Float / Outstanding35.7M / 43.2M
Vol / Avg.194.9K / 577.9K
Mkt Cap279.2M
P/E-
50d Avg. Price6.47
Div / Yield-
Payout Ratio-
EPS-0.64
Total Float35.7M
load more
Sector: Health Care.Industry: Biotechnology
Eiger BioPharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of drugs for serious, rare, and ultra-rare diseases with high unmet medical needs and no approved therapies. Its program lonafarnib, a prenylation inhibitor, boosted with ritonavir, for the treatment of Hepatitis Delta Virus (HDV) infection, is in Phase 3 clinical development. Its product candidate pipeline includes Lonafarnib (LNF) in HDV, Peginterferon Lambda (lambda) in HDV, LNF in Progeria, and Progeroid Laminopathies (PL), Avexitide in Post-Bariatric Hypoglycemia (PBH), and Avexitide in Congenital Hyperinsulinism (CHI), all advancing toward Phase 3.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-0.640-0.640 0.0000
REV4.040M2.673M-1.367M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Eiger BioPharmaceuticals Questions & Answers

Q
How do I buy Eiger BioPharmaceuticals (EIGR) stock?
A

You can purchase shares of Eiger BioPharmaceuticals (NASDAQ: EIGR) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Eiger BioPharmaceuticals's (EIGR) competitors?
Q
What is the target price for Eiger BioPharmaceuticals (EIGR) stock?
A

The latest price target for Eiger BioPharmaceuticals (NASDAQ: EIGR) was reported by Citigroup on Monday, August 9, 2021. The analyst firm set a price target for 27.00 expecting EIGR to rise to within 12 months (a possible 317.96% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Eiger BioPharmaceuticals (EIGR)?
A

The stock price for Eiger BioPharmaceuticals (NASDAQ: EIGR) is $6.46 last updated Today at June 27, 2022, 6:54 PM UTC.

Q
Does Eiger BioPharmaceuticals (EIGR) pay a dividend?
A

There are no upcoming dividends for Eiger BioPharmaceuticals.

Q
When is Eiger BioPharmaceuticals (NASDAQ:EIGR) reporting earnings?
A

Eiger BioPharmaceuticals’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Eiger BioPharmaceuticals (EIGR) going to split?
A

There is no upcoming split for Eiger BioPharmaceuticals.

Q
What sector and industry does Eiger BioPharmaceuticals (EIGR) operate in?
A

Eiger BioPharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.